Allos says FDA clears lymphoma drug Folotyn - Forbes
TopNews United StatesAllos says FDA clears lymphoma drug FolotynForbesThe approval was sped up because peripheral T-cell lymphoma is an uncommon disease and no other treatments are available, the FDA said. ...FDA OKs Allos' lymphoma Drug Folotyn; Shares UpWall Street JournalFolotyn Approved for Aggressive Type of Non-Hodgkin's lymphomaAtlanta Journal ConstitutionFDA Approves Allos lymphoma Drug: BioBuzzTheStreet.comReuters�-RTT News�-BioWorld Onlineall 77 news articles��
Blog Marketing
Post a Comment